Articles dans des revues avec comité de lecture (100)
  1. 49. Arcolia, V., Boutry, S., Laurent, S., Saussez, S., Journé, F., Wattier, A., Leteurtre, E., Renaud, F., Gabius, H.-J., Remmelink, M., Decaestecker, C., & Rodriguez, A. (2017). Galectin-1 is a diagnostic marker involved in thyroid cancer progression. International journal of oncology, 51(3), 760-770. doi:10.3892/ijo.2017.4065
  2. 50. Kindt, N., Saussez, S., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P. O., & Journé, F. (2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral oncology, 67, 183-191. doi:10.1016/j.oraloncology.2017.02.023
  3. 51. Najar, M., Fayyad Kazan, H., Faour, W., Badran, B., Journé, F., & Lagneaux, L. (2017). Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response. Inflammation research, 66(2), 129-139. doi:10.1007/s00011-016-1000-8
  4. 52. Arcolia, V., Journé, F., Renaud, F., Leteurtre, E., Gabius, H.-J., Remmelink, M., & Saussez, S. (2017). Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer. Oncology Letters, 14(4), 4183-4189. doi:10.3892/ol.2017.6719
  5. 53. Kindt, N., Saussez, S., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Pottier, C., Larsimont, D., Journé, F., & Delvenne, P. O. (2016). Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. Oral oncology, 62, 1-10. doi:10.1016/j.oraloncology.2016.08.016
  6. 54. Kindt, N., Journé, F., Laurent, G., & Saussez, S. (2016). Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets (Review). Oncology Letters, 12(4), 2247-2253. doi:10.3892/ol.2016.4929
  7. 55. Brouwers, B., Bechter, O., Bailur, J. K., Kenis, C., Laenen, A., Schöffski, P., Pawelec, G., Journé, F., Ghanem, G. E., Wildiers, H., Hatse, S., Dal Lago, L., Neven, P., Vuylsteke, P., Dalmasso, B., Debrock, G., Van Den Bulck, H., & Smeets, A. (2016). The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters. Oncotarget, 7(21), 29977-29988. doi:10.18632/oncotarget.8796
  8. 56. Krayem, M., Journé, F., Wiedig, M., Morandini, R., Najem, A., Sales, F., van Kempen, L., Sibille, C., Awada, A., Marine, J.-C., & Ghanem, G. E. (2016). P53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib. European journal of cancer, 55, 98-110. doi:10.1016/j.ejca.2015.12.002
  9. 57. Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Larsimont, D., Andry, G., Hassid, S., Rodriguez, A., Khalifé, M., Journé, F., & Saussez, S. (2016). Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Journal of cancer research and clinical oncology, 142(10), 2185-2196. doi:10.1007/s00432-016-2203-7
  10. 58. El Hajj, P., Gilot, D., Migault, M., Theunis, A., van Kempen, L., Sales, F., Fayyad Kazan, H., Badran, B., Larsimont, D., Awada, A., Bachelot, L., Galibert, M. D., Ghanem, G. E., & Journé, F. (2015). SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. British Journal of Cancer, 113(1), 91-98. doi:10.1038/bjc.2015.194
  11. 59. Verfaillie, A., Van Den Mooter, L., Claerhout, S., Fiers, M., Journé, F., Ghanem, G. E., Herrmann, C., Halder, G., Marine, J.-C., Aerts, S., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., & Luciani, F. (2015). Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nature communications, 6, 6683. doi:10.1038/ncomms7683
  12. 60. El Hajj, P., Krayem, M., Fayyad Kazan, H., Badran, B., Ghanem, G. E., & Journé, F. (2015). Differential expression profiles of microRNAs involved in malignant melanocyte pigmentation. International Journal of Biological & Pharmaceutical Research, 6, 411-418.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>